High-activity binding peptides (left) that have been chemically modified in specific places so that they fitted into the MHC class II T-cell receptor complex would be immunogenic and protection-inducing (right) in Aotus monkeys. This would be a method for developing a subunit-based synthetic malaria vaccine.